August 19, 2021
10 min listen
Save
Top news this week: FDA OKs single-use bronchoscope; CMS nixes 'most-favored nation' model; and more
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
This week, the FDA approves single-use bronchoscopes; a study finds the Moderna COVID-19 vaccine is safe and effective in adolescents; CMS nixes the most-favored nation pricing model for Medicare Part B; and more.
Read the full coverage here:
Single-use bronchoscope receives FDA clearance
Moderna COVID-19 vaccine safe, efficacious in adolescents
Adoption of newer antifibrotic medications for IPF low in US in everyday practice: Study
FDA allows third dose of COVID-19 vaccine for immunocompromised patients
CMS nixes 'most-favored nation' pricing model for Medicare Part B
References:
Ali K, et al. N Engl J Med. 2021;doi:10.1057/NEJMoa2109522.
Dempsey TM, et al. Ann Am Thorac Soc. 2021;doi:10.1513/AnnalsATS.202007-901OC.
Sources/Disclosures
Collapse
Disclosures:
Please see each study for relevant financial disclosures.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
